Exploring public preferences for potential use of MCD tests in Australia, to identify future patient-centred approaches

It is vital to understand Australians’ preferences around any potential new approach to cancer screening, so that any new screening program is acceptable, equitable, and will have a high uptake. This research activity focuses on capturing the views of the general public on MCD testing and potential follow-up steps. As part of this, we will look at how much people value different aspects. For example, how many cancers are covered by an MCD test, or how the follow-up happens.
Using established health economics techniques, we will quantify what matters most to the public and estimate potential uptake of MCD tests for cancer screening under different scenarios.

This work will provide valuable evidence to guide future implementation trials and provide the foundation for a patient-centred approach to integrating MCD tests into the healthcare system. The results will also help prioritise scenarios for our evaluations of MCD test benefits and harms, and inform our Roadmap recommendations on future implementation.

This research activity is led by A/Prof Alison Pearce (The Daffodil Centre).